Despite the prominence of diabetes prevalence (more than 8% of the world population in 2012) and its expected increase in the next 15 years, Charcot foot remains a widely unknown diabetes complication. At this day, there is no national guidelines about diagnosis and treatment of this complication, which is known to alter life quality and to increase risk of foot ulceration and mortality in diabetics. Through this descriptive multicentric study, we will investigate the Charcot foot cares in diabetic-foot centers in France and Belgium.
Study Type
OBSERVATIONAL
Enrollment
1,160
CHU de Nîmes - Hôpital Universitaire de Réadaptation du Grau du Roi
Le Grau-du-Roi, France
Nimes University Hospital
Nîmes, France
Charcot foot's diagnostic criteria
triggering factors : yes/no acute symptoms : : yes/no chronic symptoms : yes/no Presence of associated soft tissue infection : yes/no Presence of an associated bone infection : yes/no examinations performed to confirm the diagnosis of Charcot : yes/no
Time frame: inclusion visit
Description Charcot foot's treatment
Discharge used in acute phase and/or in case of wound : yes/no Shoes used in chronic phase : yes/no
Time frame: inclusion visit
Number of Charcot foot
To determine diabetic patients' number with acute or chronic Charcot foot cared in diabetic-foot center in France and Belgium over a year (estimation of Charcot foot's incidence in diabetic-foot centers).
Time frame: inclusion visit
Surgery of Charcot foot
To identify which diabetic-foot centers propose surgical management in Charcot foot, to describe the type of surgery and the indications of surgical treatment.
Time frame: inclusion visit
Register of Charcot foot
participation to a register of Charcot foot : yes/no
Time frame: inclusion visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.